OR WAIT 15 SECS
Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.
by Jill Wechsler Manufacturers are concerned about congressional efforts to establish a Medicare pharmacy benefit and to regulate research while FDA shifts regulation of biologics and other drugs.
Related Content: